Bruker to acquire assets of Nanostring
Bruker will pay about $392.6 million in cash to acquire most of the assets of Nanostring, a provider of research tools for spatial biology and gene expression according to Nanostring
The sale will conclude Nanostring’s bankruptcy proceeding and restructuring process, the Seattle-based company said. When it filed for Chapter 11 protection in February, Nanostring disclosed it had received multiple early indications of interest from possible acquirers. Bruker’s acquisition, which includes the assumption of certain liabilities, will allow Nanostring’s business operations and product development initiatives to continue for customers and substantially all of the company’s employees.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins